Mutagenic activity of 4-nitroquinoline-N-oxide in upper aerodigestive tissue in lacZ mice (Muta(TM)Mouse) and the effects of 1,4- phenylenebis(methylene)selenocyanate

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 466, Issue 1, 2000, Pages 71-78

  Von Pressentin, Marcia D M ^a   El Bayoumy, Karam ^b   Guttenplan, Joseph B ^a  

^a NEW YORK UNIVERSITY   (United States)

^b AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

4 Nitroquinoline N oxide; Aerodigestive; lacZ; Muta(TM)Mouse selenium; Mutagenesis

Indexed keywords

1,4 PHENYLENEBIS(METHYLENE)SELENOCYANATE; 4 NITROQUINOLINE 1 OXIDE; CYANIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CYTOGENETICS; DRUG MECHANISM; MALE; MOUSE; MOUTH CANCER; MUTAGEN TESTING; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; ANTICARCINOGENIC AGENTS; BACTERIOPHAGES; COLON; DNA; ESOPHAGUS; LIVER; LUNG; MALE; MICE; MOUTH; MUTAGENICITY TESTS; MUTAGENS; MUTATION; ORGANOSELENIUM COMPOUNDS; TONGUE;

ANIMALIA;

EID: 0034599054     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(00)00005-X     Document Type: Article

References (45)

1. [1] S.H. Landis, T. Murray, S. Bolden, P.A. Wingo, Cancer statistics, Can. J. Clin. 48 (1998) 6-29.
2. [2] G. Shklar, J. Schwartz, D. Grau, D.P. Trickler, K.D. Wallace, Inhibition of hamster buccal pouch carcinogenesis by 13-cis-retinoic acid, Oral Surg. Oral Med. Oral Pathol. 50 (1980) 45-52.
3. [3] H. Makita, T. Tanaka, H. Fujitsuka, N. Tatematsu, K. Satoh, A. Hara, H. Mori, Chemoprevention of 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis by the dietary flavonoids chalcone, 2-hydroxychalcone, and quercetin, Cancer Res. 56 (1996) 4904-4909.
4. [4] J.M. Nauta, L.N. Roodenburg, P.G.J. Nikkels, Comparison of epithelial dysplasia - the 4-NQO rat palate model and the human oral mucosa, Int. J. Oral Maxillofac. Surg. 24 (1995) 53-58.
5. [5] G.S. Provost, P.L. Kretz, R.T. Hamner, C.D. Matthews, B.J. Rogers, K.S. Lundberg, M.J. Dycaico, J.M. Short, Transgenic systems for in vivo mutation analysis, Mutat. Res. 288 (1993) 133-149.
6. [6] P. Schmezer, C. Eckert, U.M. Liegibel, R.G. Klein, H. Bartsch, Use of transgenic mutational test systems in risk assessment of carcinogens, Arch. Toxicol. Suppl. 20 (1998) 321-330.
7. [7] N.J. Gorelick, Validation issues for the use of transgenic mouse mutation assays in risk assessment, Prog. Clin. Biol. Res. 395 (1996) 81-108.
8. [8] A. Hakura, Y. Tsutsui, J. Sonoda, J. Kai, T. Imade, M. Shimada, Y. Sugihara, T. Mikami, Comparison between in vivo mutagenicity and carcinogenicity in multiple organs by benzo[a]pyrene in the lacZ transgenic mouse (Muta ™ Mouse), Mutat. Res. 398 (1998) 123-130.
9. [9] W. Kosinska, J.B. Guttenplan, Comparative mutagenicity of benzo(a)pyrene in different organs of lacZ mice, Carcinogenesis 20 (1999) 1103-1106.
10. [10] S.J. Culp, D.W. Gaylor, W.G. Sheldon, L.S. Goldstein, F.A. Beland, A comparison of the tumors induced by coal tar and benzo[a]pyrene in a 2-year bioassay, Carcinogenesis 7 (1998) 1317-1322.
11. [11] W. Kosinska, J.B. Guttenplan, Mutagenesis by oral carcinogens in lacZ mouse oral tissue, Proc. Am. Assoc. Cancer Res. 39 (1998) 184.
12. [12] T. Tanaka, H. Makita, K. Kawabata, H. Mori, K. El-Bayoumy, 1,4-Phenylenebis(methylene)selenocyanate exerts exceptional chemopreventive activity in rat tongue carcinogenesis, Cancer Res. 57 (1997) 3644-3648.
13. [13] M. Nakajima, M. Kikuchi, K. Saeki, Y. Miyata, M. Terada, F. Kishida, R. Yamamoto, C. Furihata, S. Dean, Mutagenicity of 4-nitroquinoline 1-oxide in the Muta ™ Mouse, Mutat. Res. 444 (1999) 321-336.
14. [14] G.N. Schrauzer, S.A. White, C.J. Schneider, Cancer mortality correlation studies: III. Statistical associations with dietary selenium intakes, Bioinorg. Chem. 7 (1977) 23-31.
15. [15] W.C. Willet, J.S. Morris, S. Pressel, J.O. Taylor, B.F. Polk, M.J. Stampler, B. Rosner, K. Schneider, C.G. Hames, Prediagnostic serum selenium and risk of cancer, Lancet 11 (1983) 130-134.
16. [16] W.J.J. Goodwin, H.W. Lane, K. Bradford, M.V. Marshall, A.C. Griffin, H. Geopfert, R.H. Jesse, Selenium and glutathione peroxidase levels in patients with epidemoid carcinoma of the oral cavity and oropharynx, Cancer (Philadelphia) 51 (1983) 110-115.
17. [17] M.A.M. Rogers, D.B. Thomas, S. Davis, N.S. Weiss, T.L. Vaughan, A.E. Nevissi, A case-control study of oral cancer and pre-diagnostic concentrations of selenium and zinc in nail tissue, Int. J. Cancer 48 (1991) 182-188.
18. [18] K. Krishnaswamy, M.P.R. Prasad, T.P. Krishna, S. Passricha, A case-control study of selenium in cancer, Indian J. Med. Res. Sect. B 98 (1993) 124-128.
19. [19] L.C. Clark, J.F. Combs Jr., B.W. Turbull, E.H. Slate, D.K. Chalker, J. Chow, L.S. Davis, R.A. Glover, G.F. Graham, E.G. Gross, A. Krongrad, J.L. Lesher Jr., H.K. Park, B.B. Sanders Jr., C.L. Smith, J.R. Taylor, Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial, Nutr. Prev. Cancer Study Group, JAMA 276 (1996) 1957-1963.
20. [20] K. El-Bayoumy, The role of selenium in cancer prevention, in: V.T.J. DeVita, S. Hellman, S.A. Rosenberg (Eds.), Cancer Principles and Practice of Oncology, J.B. Lippincott, Philadelphia, 1991, pp. 1-15.
21. [21] K. El-Bayoumy, P. Upadhyaya, Y.-H. Chae, O.-S. Sohn, C.V. Rao, E. Fiala, B.S. Reddy, Chemoprevention of cancer by organoselenium, compounds, J. Cell Biochem. 22 (1995) 92-100, Suppl.
22. [22] T. Suzuki, S. Itoh, M. Nakajima, N. Hachiya, T. Hara, Target organ and time-course in the mutagenicity of five carcinogens in Muta ™ Mouse: a summary report of the second collaborative study of the transgenic mouse mutation assay, JEMS/MMS 444 (1999) 259-268.
23. - phage, Mutagenesis 9 (1994) 183-185.
24. [24] A.M. Benson, Conversion of 4-nitroquinoline 1-oxide (4-NQO) to 4-hydroxyaminoquinoline 1-oxide by a dicumarol-resistant hepatic 4-NQO nitroreductase in rats and mice, Biochemical Pharmacology 46 (1993) 1217-1221.
25. [25] D.R. Booth, A relationship found between intra-oral sites of 4-NQO reductase activity and chemical carcinogenesis, Cell and Tissue Kinetics 23 (1990) 331-340.
26. [26] C.E. Cross, B. Haliwell, E.T. Borish, W.A. Prayor, B.N. Ames, R.L. Saul, J.M. McCord, D. Harman, Oxygen radicals and human disease, Ann. Intern. Med. 107 (1987) 526-545.
27. [27] W. Troll, R. Weisner, The role of oxygen radicals as a possible mechanism of tumor promotion, Annu. Rev. Pharmacol. Toxicol. 25 (1985) 509-528.
28. [28] K. Frenkel, Oxidation of DNA bases by tumor promoter-activated processes, Environ. Health Perspect. 81 (1989) 45-54.
29. [29] K. Yamamoto, S. Inou, S. Kawanishi, Site-specific DNA damage and 8-hydroxydeoxyguanosine formation by hydroxylamine and 4-hydroxylaminoquinoline-1-oxide in the presence of Cu (II): role of reactive oxygen species, Carcinogenesis 14 (1993) 1397-1401.
30. [30] K. Kohda, M. Tada, H. Kasai, S. Nishmura, Y. Kawazoe, Formation of 8-hydroxyguanine residues in cellular DNA exposed to the carcinogen 4-nitroquinoline-1-oxide, Biochem. Biophys. Res. Commun. 139 (1986) 626-632.
31. [31] K. El-Bayoumy, Y.-H. Chae, P. Upadhyaya, C. Meschter, L.A. Cohen, B.S. Reddy, Inhibition of 7,12-dimethylbenz(a)anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound 1,4-phenylenebis(methylene) selenocyanate, Cancer Res. 52 (1992) 2402-2407.
32. [32] B. Prokopczyk, J.E. Cox, P. Upadhyaya, S. Amin, D. Desai, D. Hoffmann, K. El-Bayoumy, Effects of dietary 1,4-phenylenebis(methylene)selenocyanate on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA adduct formation in lung and liver of A/J mice and F-344 rats, Carcinogenesis 17 (1996) 749-753.
33. [33] J.G. Rosa, B. Prokopczyk, D.H. Desai, S.G. Amin, K. El-Bayoumy, Elevated 8-deoxyguanosine levels in lung DNA of A/J mice and F344 rat treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and inhibition by dietary 1,4-phenylenebis(methylene)selenocyanate, Carcinogenesis 19 (1998) 1783-1788.
34. [34] K. El-Bayoumy, Y.-H. Chae, J.G. Rosa, L.K. Williams, D. Desai, Amin, Shantu, E. Fiala, The effects of 1-nitropyrene, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene on 8-hydroxy-2-2′-deoxyguanosine levels in the rat mammary gland and modulation by dietary 1,4-phenylenebis(methylene)selenocyanate, Carcino-genesis (1999) in press.
35. [35] B.S. Reddy, A. Rivenson, N. Kalkarni, P. Upadhyaya, K. El-Bayoumy, Chemoprevention of colon carcinogenesis by the synthetic organoselenium compound, 1,4-phenylenebis-(methylene)selenocyanate, Cancer Res. 52 (1992) 5635-5640.
36. [36] O.-S. Sohn, E.S. Fiala, P. Upadhyaya, Y.-H. Chae, K. El-Bayoumy, Comparative effects of phenylenebis(methylene)-selenocyanate on xenobiotic metabolizing enzymes in organs of female CD rats, Carcinogenesis 20 (1999) 615-621.
37. [37] B.S. Reddy, T.T. Wynn, K. El-Bayoumy, P. Upadhyaya, E. Fiala, C.V. Rao, Evaluation of organoselenium compounds for potential chemopreventive properties in colon cancer, Anticancer Res. 16 (1996) 1123-1128.
38. [38] H.S. Samaha, R. Hamid, K. El-Bayoumy, P. Upadhyaya, C.V. Rao, B.S. Reddy, The role of apoptosis in the modulation of colon carcinogenesis by dietary fat and by the organoselenium compound 1,4-phenylene(bis)methylene selenocyanate, Cancer Epidemiol. Biomarkers Prev. 6 (1997) 1997.
39. [39] J.K. Tillotson, P. Upadhyaya, Z. Ronai, Inhibition of thymidine kinase in cultured mammary tumor cells by the chemopreventive organoselenium compound, 1,4-phenylene-bis(methylene)selenocyanate, Carcinogenesis 15 (1995) 607-610.
40. [40] P.G. Foiles, H. Fujiki, M. Suganuma, S. Okabe, J. Yatsunami, L.M. Miglietta, P. Upadhyaya, K. El-Bayoumy, Z. Ronai, Inhibition of PKC and PKA by chemopreventive organoselenium compounds, Int. J. Oncol. 7 (1995) 685-690.
41. [41] Z. Ronai, F. Traganos, Z. Darzynkiewicz, J.K. Tillotson, C.C. Conaway, P. Upadhyaya, K. El-Bayoumy, Effects of organic and inorganic selenium compounds on rat mammary tumor cells, Int. J. Cancer 63 (1995) 428-434.
42. [42] H.J. Thompson, A. Wilson, J. Lu, M. Singh, C. Jiang, P. Upadhyaya, K. El-Bayoumy, C. Ip, Comparison of the effects of an organic and inorganic form of selenium on a mammary carcinoma cell line, Carcinogenesis 15 (1994) 183-186.
43. [43] V. Adler, M.R. Pincus, S. Posner, P. Upadhyaya, K. El-Bayoumy, Z. Ronai, Effects of chemopreventive selenium compounds on Jun N-kinase activities, Carcinogenesis 17 (1996) 1849-1854.
44. [44] W.W. Piegorsch, B.H. Margolin, M.D. Shelby, A. Johnson, J.E. French, R.W. Tennant, K.R. Tindall, Study design and sample sizes for lacI transgenic mouse mutation assay, Environ. Mol. Mutagen. 25 (1995) 231-245.
45. [45] T.R. Skopek, K.L. Kort, D.R. Marino, L.V. Mittal, D.R. Umbenhauer, G.M. Laws, S.P. Adams, Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big blue B6C3F1 mice, Environ. Mol. Mutagen. 28 (1996) 376-384.